Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134549) titled 'Association of the Hepcidin-Ferroportin Axis with Vascular Calcification in CKD' on Oct. 16.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Drum Tower Hospital
Condition:
chronic kidney disease
Intervention:
Control group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2027-01-01
Target Sample Size: Control group:50;CKD group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341727
Disclaimer: Curated by HT Syndication....